| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S Weyerer, H Dillin. Psychiatric and physical illness, sociodemographic characteristics, and the use of psychotropic drugs in the community: results from the Upper Bavarian Field Study. Journal of clinical epidemiology. vol 44. issue 3. 1991-04-11. PMID:1999690. |
a large proportion (63.0%) of those with previous psychiatric in- and outpatient treatment received psychotropic medication, as well as those suffering from schizophrenia (66.7%), affective psychoses (52.6%) and anxiety disorders (50.0%). |
1991-04-11 |
2023-08-11 |
Not clear |
| H B Demb, A G Weintrau. A five-year follow-up of preschool children diagnosed as having an atypical pervasive developmental disorder. Journal of developmental and behavioral pediatrics : JDBP. vol 10. issue 6. 1990-02-07. PMID:2600185. |
a broader range of symptoms (including positive symptoms of schizophrenia and signs of affective and anxiety disorders) were noted. |
1990-02-07 |
2023-08-11 |
Not clear |
| J L Black, B K Bruc. Behavior therapy: a clinical update. Hospital & community psychiatry. vol 40. issue 11. 1989-12-08. PMID:2680882. |
after outlining the four models that serve as a framework for behavior therapy (classical conditioning, operant conditioning, social learning theory, and cognitive behavior modification), the authors provide an update for clinicians on developments in the behavioral treatment of anxiety disorders, sexual disorders, depression, and schizophrenia. |
1989-12-08 |
2023-08-11 |
Not clear |
| G R Heninger, D S Charne. Monoamine receptor systems and anxiety disorders. The Psychiatric clinics of North America. vol 11. issue 2. 1988-10-24. PMID:2843838. |
stimulation of the 5-ht system does not produce marked abnormalities in patients, but stimulation of the ne system does produce abnormal changes in measures of anxiety, somatic symptoms, blood pressure, and a plasma ne metabolite and cortisol levels in patients with panic disorder but not in patients with generalized anxiety disorder, obsessive-compulsive disorder, depression, or schizophrenia. |
1988-10-24 |
2023-08-11 |
Not clear |
| P A Jansse. The relevance of pharmacological studies to sleep research in psychiatry. Pharmacopsychiatry. vol 21. issue 1. 1988-06-09. PMID:3129746. |
the pronounced thymosthenic effect observed with this compound in patients suffering from dysthymia, generalized anxiety disorder and negative symptoms of schizophrenia can possibly be attributed to a restoration of the energetic function during the night as a consequence of a dramatic increase in slow wave sleep during treatment with ritanserin. |
1988-06-09 |
2023-08-11 |
human |
| M R Liebowit. Newer uses for older psychotropic medications. Hospital & community psychiatry. vol 33. issue 4. 1982-07-08. PMID:6122638. |
among the more important recent discoveries are the efficacy of the tricyclic antidepressants for panic disorder and agoraphobia with panic attacks; the use of the monoamine oxidase inhibitors for the above disorders and for atypical depression and hysteroid dysphoria; the use of propranolol for anxiety disorders and for uncontrollable violent outbursts; the antianxiety and antipanic effects of clonidine; and the usefulness of lithium in treating schizophrenia and schizoaffective disorder and for emotionally unstable character disorders. |
1982-07-08 |
2023-08-12 |
Not clear |